BellTissue Engineering
Current Perspectives
1 Tissue Engineering, An Overview.- I Matrix Molecules and Their Ligands.- 2 Role of Non-Fibrillar Collagens in Matrix Assemblies.- 3 Elastic Fiber Organization.- II USE of Cultured Cells and the Potential of Stem Cells for Tissue Restoration.- 4 Myoblast Mediated Gene Therapy.- 5 Implantation of Cultured Schwann Cells to Foster Repair in Injured Mammalian Spinal Cord.- 6 Progenitor Cells in Embryonic and Post-Natal Rat Livers, Their Growth and Differentiation Potential.- III Co-Cultures and Other in Vitro Systems for Promoting Differentiation and Tissue Formation.- 7 Extracellular Matrix, Cellular Mechanics, and Tissue Engineering.- 8 Modulation of Cardiac Growth by Sympathetic Innervation: Differential Response Between Normotensive and Hypertensive Rats.- 9 Liver Support Through Hepatic Tissue Engineering.- IV Physical Forces as Requirements for Gene Expression, Growth, Morphogenesis, and Differentiation.- 10 Evidence for the Role of Physical Forces in Growth, Morphogenesis, and Differentiation.- 11 Physical Stress as a Factor in Tissue Growth and Remodeling.- 12 Mechanical Stress Effects on Vascular Endothelial Cell Growth.- 13 Deformation of Chondrocytes Within the Extracellular Matrix of Articular Cartilage.- 14 Mechanical Stretch Rapidly Activates Multiple Signaling Pathways in Cardiac Myocytes.- 15 Shear Stress-Induced Gene Expression in Human Endothelial Cells.- V Materials for Tissue Remodeling in Vivo and in Vitro.- 16 Tissue Engineering of Skeletal and Cardiac Muscle for Correction of Congenital and Genetic Abnormalities and Reconstruction Following Physical Damage.- 17 Small Intestinal Submucosa (SIS): A Biomaterial Conducive to Smart Tissue Remodeling.- 18 Matrix Engineering: Remodeling of Dense Fibrillar Collagen Vascular Grafts In Vivo.- 19 Bioelastic Materials as Matrices for Tissue Reconstruction.- VI Approaches to Allografting Engineered Cells and Tissues.- 20 Induction of Immunological Unresponsiveness in the Adult Animal.- 21 "Neutral Allografts" Cultured Allogenic Cells as Building Blocks of Engineered Organs Transplanted Across MHC Barriers.
